![](/img/cover-not-exists.png)
Cost-effectiveness and quality-of-life assessment of GM-CSF as an adjunct to intensive remission induction chemotherapy in elderly patients with acute myeloid leukaemia
Uyl-DE Groot, LÖwenberg, Vellenga, Suciu, Willemze, RuttenVolume:
100
Year:
1998
Language:
english
Pages:
8
DOI:
10.1046/j.1365-2141.1998.00635.x
File:
PDF, 327 KB
english, 1998